NLS Pharmaceutics

-$0.03 (-0.97%) Today
-$0.04 (-1.31%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NLSP and other stocks, options, and ETFs commission-free!

About NLSP

NLS Pharmaceutics Ltd. engages in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders, including narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder(ADHD). The company was founded by Ronald Hafner and Alexander Zwyer in August 2015 and is headquartered in Stans, Switzerland.

CEO
Alexander Zwyer
Employees
6
Headquarters
Stans, Nidwalden
Founded
2015

NLSP Key Statistics

Market Cap
40.36M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
338.01K
High Today
$3.11
Low Today
$3.03
Open Price
$3.11
Volume
122.14K
52 Week High
$7.35
52 Week Low
$2.06

NLSP Earnings

Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jul 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure